CSE:XTRX

Phyto Extractions Announces Interim CEO and Director Transition

Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE:XTRX) (FRA:D2EP) ("Phyto Extractions" or the "Company") announces that interim CEO J. Scott Munro has transitioned from his roles as Interim CEO and director of the Company to new external ventures. With his experience in C-suite positions in various private and public companies and wealth of management knowledge, Munro served as a seasoned driver whose role as Interim CEO and director steadily steered Phyto Extractions on its continued growth trajectory, overseeing a new project category launch and several corporate operational improvements

"Scott Munro has made his own patch on the tapestry of Phyto Extractions' history. Phyto Extractions has seen vast improvements across operations and the financial health of the company during his tenure, which isn't an easy task for any senior manager," said Donald Dinsmore, Chief Operating Officer. "We are grateful for Munro's support and the improvements he has made for the company during his period as interim CEO and we wish him all the best in his new endeavors."

The Company has identified a new permanent candidate for the role of CEO and an additional director to fill the vacancy created by Mr. Munro's transition. The Company expects to announce such appointments in the immediate future. The Company anticipates that such appointments will continue the great work completed to date that has positioned the brand of providing quality cannabis products to its valued customers.

Phyto Extractions will continue executing on its operational excellence, securing ever increasing market share and positioning itself as one of the leading cannabis brand name products, with the help of its wholly-owned subsidiaries Adastra Labs Inc. and testing lab Chemia Analytics Inc.

About Phyto Extractionsâ„¢

Phyto Extractions Inc. is a Langley, BC-based cannabis company with a co-located Health Canada Licensed Standard Processing Facility and Analytical Testing Laboratory. Pioneering in cannabis products like shatter and extracts, Phyto Extractionsâ„¢ adopts strict in-process quality tests for cannabis extraction methods, like hydrocarbon and cryo-ethanol extractions to ensure high-quality extracts are enjoyed by cannabis enthusiasts. The Company offers a range of products from vape cartridges to pure cannabis extracts that can be incorporated into daily usage.

ON BEHALF OF THE BOARD

PHYTO EXTRACTIONS INC.

Per: "Stephen Brohman"
Stephen Brohman
Chief Financial Officer and Director
Phone: (778) 715-5011

Forward-Looking Information:

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect to the appointment of future director and officers and the growth of the Company on a going forward basis. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; and (iii) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

The CSE has not reviewed or approved of any contents of this news release.

SOURCE: Phyto Extractions Inc.



View source version on accesswire.com:
https://www.accesswire.com/643686/Phyto-Extractions-Announces-Interim-CEO-and-Director-Transition

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
adastra labs

Adastra Holdings

Purveyor of Quality Cannabis Derivatives and Award-Winning Extracts

Purveyor of Quality Cannabis Derivatives and Award-Winning Extracts Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News